Volume 18(6); 2022

Acceptance – Commentary

How to counter the anti-vaccine rhetoric: Filling information voids and building resilience

Federico Germani, Nikola Biller-Andorno

Hum Vaccin Immunother. 2022; 18(6): 2095825. Published online 2022 Jul 8. doi: 10.1080/21645515.2022.2095825

PMCID:: PMC9746393

Article PDF–1.0M

Acceptance – Letters

Routine OSCE to identify core communication skills required for counseling a vaccine-hesitant patient: Correspondence

Amnuay Keebayoon, Viroj Wiwanitkit

Hum Vaccin Immunother. 2022; 18(6): 2099165. Published online 2022 Jul 26. doi: 10.1080/21645515.2022.2099165

PMCID:: PMC9746441

Article PDF–157K

Acceptance – Research Article

Disparities in full immunization coverage among urban and rural children aged 12-23 months in southwest Ethiopia: A comparative cross-sectional study

Getachew Asmare, Merkine Madalicho, Abebe Sorsa

Hum Vaccin Immunother. 2022; 18(6): 2101316. Published online 2022 Sep 2. doi: 10.1080/21645515.2022.2101316

PMCID:: PMC9746474

Article PDF–1.5M

Theories-based determinants analysis of Hib-combined vaccine hesitancy in China: A multi-group structural equation modeling

Xuewen Jiang, Junfen Lin, Wei Wang, Yanrong Zhao, Yinwei Qiu

Hum Vaccin Immunother. 2022; 18(6): 2104057. Published online 2022 Oct 26. doi: 10.1080/21645515.2022.2104057

PMCID:: PMC9746522

Article PDF–734K

Assessment of training of general practice interns in motivational interviews about vaccination

Eva Mitilian, Virginie Gosselin, Ludovic Casanova, Lisa Fressard, Patrick Berthiaume, Pierre Verger, Arnaud Gagneur

Hum Vaccin Immunother. 2022; 18(6): 2114253. Published online 2022 Sep 15. doi: 10.1080/21645515.2022.2114253

PMCID:: PMC9746523

Article PDF–721K

Vaccine confidence among people who use drugs: A cross-sectional survey

Paula M. Frew, Jay T. Schamel, Laura A. Randall, Adrian R. King, Anne C. Spaulding, Elizabeth Wu, Ian W. Holloway

Hum Vaccin Immunother. 2022; 18(6): 2123201. Published online 2022 Sep 28. doi: 10.1080/21645515.2022.2123201

PMCID:: PMC9746418

Article PDF–470K

Determinants of basic childhood vaccination coverage in European and OECD countries

Vladimira Varbanova, Frederik Verelst, Niel Hens, Philippe Beutels

Hum Vaccin Immunother. 2022; 18(6): 2123883. Published online 2022 Sep 29. doi: 10.1080/21645515.2022.2123883

PMCID:: PMC9746410

Article PDF–2.2M

Vaccine hesitancy and its determinants among refugee parents resettled in Aotearoa New Zealand

Mulisa Senbeta Debela, A. P. Nick Garrett, Nadia A. Charania

Hum Vaccin Immunother. 2022; 18(6): 2131336. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2131336

PMCID:: PMC9746517

Article PDF–383K

Acceptance – Review

Vaccine hesitancy in the refugee, immigrant, and migrant population in the United States: A systematic review and meta-analysis

Danielle Daniels, Aamer Imdad, Teaghen Buscemi-Kimmins, Danielle Vitale, Uzma Rani, Ellen Darabaner, Andrea Shaw, Jana Shaw

Hum Vaccin Immunother. 2022; 18(6): 2131168. Published online 2022 Nov 4. doi: 10.1080/21645515.2022.2131168

PMCID:: PMC9746503

Article PDF–759K

Factors affecting childhood immunization: Thematic analysis of parents and healthcare workers’ perceptions

Preeti Balgovind, Masoud Mohammadnezhad

Hum Vaccin Immunother. 2022; 18(6): 2137338. Published online 2022 Nov 3. doi: 10.1080/21645515.2022.2137338

PMCID:: PMC9746479

Article PDF–375K

Clinical – Commentary

Vaccine regulation should require and enforce the inclusion of pregnant and breastfeeding women in prelicensure clinical trials

Terra A. Manca, Manish Sadarangani, Scott A. Halperin, Joanne M. Langley, Elisabeth McClymont, Shannon E. MacDonald, Karina A. Top

Hum Vaccin Immunother. 2022; 18(6): 2104019. Published online 2022 Jul 26. doi: 10.1080/21645515.2022.2104019

PMCID:: PMC9746508

Article PDF–214K

Coronavirus – Article Commentary

Addressing COVID-19 vaccine hesitancy in South Africa- moving beyond a reliance on information-based responses

Sara Cooper, Heidi van Rooyen, Charles S. Wiysonge

Hum Vaccin Immunother. 2022; 18(6): 2107851. Published online 2022 Aug 22. doi: 10.1080/21645515.2022.2107851

PMCID:: PMC9746356

Article PDF–210K

Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries

D. August Oddleifson, Jehanzeb Kayani, Rhea Shrivastava, Jenny Tan, Maike Winters, Howard Forman, Saad B. Omer

Hum Vaccin Immunother. 2022; 18(6): 2124781. Published online 2022 Oct 21. doi: 10.1080/21645515.2022.2124781

PMCID:: PMC9746604

Article PDF–457K

Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary

Trésor Zola Matuvanga, Reena H. Doshi, Albert Muya, Aimé Cikomola, Augustin Milabyo, Pablito Nasaka, Patrick Mitashi, Hypolite Muhindo-Mavoko, Steve Ahuka, Michel Nzaji, Nicole A. Hoff, Robert Perry, Elisabeth Mukamba Musenga

Hum Vaccin Immunother. 2022; 18(6): 2127272. Published online 2022 Sep 27. doi: 10.1080/21645515.2022.2127272

PMCID:: PMC9746480

Article PDF–308K

Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning

Robert A. Johnson, Richard C. White, Gary L. Disbrow

Hum Vaccin Immunother. 2022; 18(6): 2129930. Published online 2022 Oct 27. doi: 10.1080/21645515.2022.2129930

PMCID:: PMC9746534

Article PDF–699K

Coronavirus – Brief Report

Different T-cell and B-cell repertoire elicited by the SARS-CoV-2 inactivated vaccine and S1 subunit vaccine in rhesus macaques

Li Qin, Yuanyuan Zuo, Shuying Liu, Bingxiang Li, Hongye Wang, Heng Li, Jing Li, Yanli Chen, Ming Sun, Huiwen Zheng

Hum Vaccin Immunother. 2022; 18(6): 2118477. Published online 2022 Sep 7. doi: 10.1080/21645515.2022.2118477

PMCID:: PMC9746386

Article PDF–7.2M

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees

Francesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, Claudia Semplici, Pietro Piu, Giulia Piccini, Linda Benincasa, Serena Marchi, Emanuele Andreano, Piero Lovreglio, Nicola Buonvino, Nicola Decaro, Angela Stufano, Eleonora Lorusso, Emilio Bombardieri, Antonella Ruello, Simonetta Viviani, Rino Rappuoli, Eleonora Molesti, Alessandro Manenti, Emanuele Montomoli

Hum Vaccin Immunother. 2022; 18(6): 2129196. Published online 2022 Oct 21. doi: 10.1080/21645515.2022.2129196

PMCID:: PMC9746531

Article PDF–1.5M

Effects of coronavirus pandemic on expanded program on immunization in weija gbawe municipality (Accra-Ghana)

Jonathan Kissi, Joseph Owusu-Marfo, Ernest Osei, Kennedy Dzamvivie, Vivian Akorfa Anku, Jessica Naa Lamiokor Lamptey

Hum Vaccin Immunother. 2022; 18(6): 2129830. Published online 2022 Oct 4. doi: 10.1080/21645515.2022.2129830

PMCID:: PMC9746378

Article PDF–1.6M

Expanding access to COVID-19 testing, vaccination and treatment at a free clinic for uninsured Spanish-speaking adults in Providence, RI

Katherine Barry, Johanna A. Suskin, Julia Testa, Morgan Leonard, Anne S. De Groot

Hum Vaccin Immunother. 2022; 18(6): 2144604. Published online 2022 Nov 14. doi: 10.1080/21645515.2022.2144604

PMCID:: PMC9746502

Article PDF–2.9M

Coronavirus – Case Report

Immunogenicity and safety of BNT162b2 mRNA COVID-19 vaccine in a subject affected by Shapiro’s syndrome: A case report

Lorenza Moscara, Silvio Tafuri, Delio Gagliardi, Pasquale Stefanizzi

Hum Vaccin Immunother. 2022; 18(6): 2094148. Published online 2022 Jun 28. doi: 10.1080/21645515.2022.2094148

PMCID:: PMC9746352

Article PDF–186K

Cerebral venous sinus thrombosis after COVID-19 vaccination and congenital deficiency of coagulation factors: Is there a correlation?

Federica Mele, Silvio Tafuri, Pasquale Stefanizzi, Antonio D Amati, Mariagrazia Calvano, Mirko Leonardelli, Enrica Macorano, Stefano Duma, Giovanni De Gabriele, Francesco Introna, Antonio De Donno

Hum Vaccin Immunother. 2022; 18(6): 2095166. Published online 2022 Jul 27. doi: 10.1080/21645515.2022.2095166

PMCID:: PMC9746424

Article PDF–2.1M

Sudden sensorineural hearing loss with intralabyrinthine hemorrhage after COVID-19 vaccination

Junhui Jeong, Pyeong Ho Yoon

Hum Vaccin Immunother. 2022; 18(6): 2097462. Published online 2022 Jul 6. doi: 10.1080/21645515.2022.2097462

PMCID:: PMC9746398

Article PDF–922K

SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case

Olgo A. Mukhina, Daria S. Fomina, Vasiliy V. Parshin, Vladimir A. Gushchin, Inna V. Dolzhikova, Alexey M. Shchetinin, Dmitriy M. Chudakov, Evgeniia Alekseeva, Dmitriy Korostin, Georgii A. Bazykin, Galya Klink, Denis Yu. Logunov, Maryana A. Lysenko

Hum Vaccin Immunother. 2022; 18(6): 2101334. Published online 2022 Aug 1. doi: 10.1080/21645515.2022.2101334

PMCID:: PMC9746374

Article PDF–348K

Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report

Guang Zeng, Jie Tang, Shuidong Feng, Liumei Xu, Xiaohui Wang, Zhengrong Yang

Hum Vaccin Immunother. 2022; 18(6): 2110799. Published online 2022 Sep 1. doi: 10.1080/21645515.2022.2110799

PMCID:: PMC9746420

Article PDF–1.0M

Miller-Fisher syndrome and Guillain–Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review

Hao Liang, Yuanbo Cao, Wei Zhong, Zhenwang Ma, Jia Liu, Hong Chen

Hum Vaccin Immunother. 2022; 18(6): 2125753. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2125753

PMCID:: PMC9746535

Article PDF–507K

Coronavirus – Commentary

Potential changes in vaccine access and policy landscape in Thailand post COVID-19 pandemic

Warittakorn Kategeaw, Sitaporn Youngkong, Suthira Taychakhoonavudh, Sirirat Techathawat, Nathorn Chaiyakunapruk

Hum Vaccin Immunother. 2022; 18(6): 2095823. Published online 2022 Jul 11. doi: 10.1080/21645515.2022.2095823

PMCID:: PMC9746520

Article PDF–451K

Coronavirus – Letter

Reponse to Letter to The Editor: Regarding: Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines

Pembe Derin Oygar, Ates Kara

Hum Vaccin Immunother. 2022; 18(6): 2106748. Published online 2022 Aug 8. doi: 10.1080/21645515.2022.2106748

PMCID:: PMC9750710

Article PDF–119K

Public attitudes on social media toward vaccination and COVID-19 pandemic: correspondence

Rujititka Mungmunpuntipantip, Viroj Wiwanitkit

Hum Vaccin Immunother. 2022; 18(6): 2114262. Published online 2022 Sep 1. doi: 10.1080/21645515.2022.2114262

PMCID:: PMC9746498

Article PDF–115K

Addressing COVID-19 vaccine hesitancy

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

Hum Vaccin Immunother. 2022; 18(6): 2124090. Published online 2022 Sep 19. doi: 10.1080/21645515.2022.2124090

PMCID:: PMC9746499

Article PDF–117K

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant

Anita M. Shete, Deepak Y. Patil, Rima R. Sahay, Gajanan N. Sapkal, Gururaj R. Deshpande, Pragya D. Yadav

Hum Vaccin Immunother. 2022; 18(6): 2127289. Published online 2022 Sep 28. doi: 10.1080/21645515.2022.2127289

PMCID:: PMC9746465

Article PDF–1.5M

The Trojan horse feature of SARS-CoV-2 behind the re-emergence of the Crimean-Congo hemorrhagic fever in Iraq

Teroj A. Mohammed, Akheenk H. Mostafa, Jivan Q. Ahmad, Nizar Bakir Yahya, Gahin A. Tayib

Hum Vaccin Immunother. 2022; 18(6): 2128610. Published online 2022 Nov 1. doi: 10.1080/21645515.2022.2128610

PMCID:: PMC9746404

Article PDF–2.0M

Inactivated COVID-19 vaccines, HBV and HIV: Correspondence

Pathum Sookaromdee, Viroj Wiwanitkit

Hum Vaccin Immunother. 2022; 18(6): 2129931. Published online 2022 Oct 26. doi: 10.1080/21645515.2022.2129931

PMCID:: PMC9746507

Article PDF–117K

Coronavirus – Letters

Neutralization of ARCoV-induced sera against SARS-CoV-2 variants

Xiao-Feng Li, Na-Na Zhang, Yu-Hua Li, Shou-Chun Cao, Yi-Fei Zhang, Cheng-Feng Qin

Hum Vaccin Immunother. 2022; 18(6): 2094142. Published online 2022 Jul 11. doi: 10.1080/21645515.2022.2094142

PMCID:: PMC9746371

Article PDF–881K

Longitudinally extensive transverse myelitis after covid vaccination: Response to letter

Seyed Farzad Maroufi, Fereshteh Naderi Behdani, Fatemeh Rezania, Samaneh Tanhapour Khotbehsara, Zahra Mirzaasgari

Hum Vaccin Immunother. 2022; 18(6): 2096378. Published online 2022 Jul 12. doi: 10.1080/21645515.2022.2096378

PMCID:: PMC9746375

Article PDF–138K

Attitudes and behavior of medical students toward receiving the COVID-19 vaccine

Pathum Sookaromdee, Viroj Wiwanitkit

Hum Vaccin Immunother. 2022; 18(6): 2096987. Published online 2022 Jul 21. doi: 10.1080/21645515.2022.2096987

PMCID:: PMC9746358

Article PDF–136K

Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable

Yandong Cheng, Taishun Li, Yi-Hua Zhou

Hum Vaccin Immunother. 2022; 18(6): 2099163. Published online 2022 Aug 5. doi: 10.1080/21645515.2022.2099163

PMCID:: PMC9746603

Article PDF–151K

Coronavirus – Research Article

Understanding the impact process of vaccine adoption for COVID-19

Wenlong Zhu, Hao Zou, Ying Song, Lili Ren, Yingjie Xu

Hum Vaccin Immunother. 2022; 18(6): 2099166. Published online 2022 Jul 29. doi: 10.1080/21645515.2022.2099166

PMCID:: PMC9746427

Article PDF–376K

Exploring the impact of Quebec’s vaccine lottery and vaccine passports on Covid-19 vaccination intention: Findings from repeated cross-sectional surveys

Ève Dubé, Maude Dionne, Louis Rochette

Hum Vaccin Immunother. 2022; 18(6): 2100168. Published online 2022 Aug 10. doi: 10.1080/21645515.2022.2100168

PMCID:: PMC9746470

Article PDF–463K

A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

Gabriel I. Nistor, Robert O. Dillman, Rockelle M. Robles, James L. Langford, Aleksandra J. Poole, Muchlis A. U. Sofro, Yetty M. Nency, Jonny Jonny, Martina L. Yana, Mahammad Karyana, Endang S. Lestari, Ria Triwardhani, Mujahidah Mujahidah, Retty K. Sari, Nur A. Soetojo, Djoko Wibisono, Daniel Tjen, Taruna Ikrar, Gregory Sarkissian, Haryono Winarta, Terawan A. Putranto, Hans S. Keirstead

Hum Vaccin Immunother. 2022; 18(6): 2100189. Published online 2022 Aug 26. doi: 10.1080/21645515.2022.2100189

PMCID:: PMC9746383

Article PDF–341K

Public attitudes on social media toward vaccination before and during the COVID-19 pandemic

Uzair Shah, Md. Rafiul Biswas, Raian Ali, Hazrat Ali, Zubair Shah

Hum Vaccin Immunother. 2022; 18(6): 2101835. Published online 2022 Aug 3. doi: 10.1080/21645515.2022.2101835

PMCID:: PMC9746453

Article PDF–3.7M

COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, China

Leiwen Fu, Shuang Wu, Bingyi Wang, Weiran Zheng, Yinghui Sun, Tian Tian, Xiaoyue Zhang, Lingrui Xu, Yukun Sun, Jie Zhan, Zhenwei Peng, Yong Chen, Huachun Zou

Hum Vaccin Immunother. 2022; 18(6): 2102329. Published online 2022 Aug 17. doi: 10.1080/21645515.2022.2102329

PMCID:: PMC9746538

Article PDF–1.3M

The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis

María M. Castrejon, Ingrid Leal, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst

Hum Vaccin Immunother. 2022; 18(6): 2102353. Published online 2022 Sep 9. doi: 10.1080/21645515.2022.2102353

PMCID:: PMC9746494

Article PDF–3.1M

Influenza vaccination coverage among health-care workers during the COVID-19 epidemic in 2020/2021 influenza season: Evidence from a web-based survey in northwestern China

Xiaojuan Shi, Ying Zhang, Luping Zhou, Liwei Zhou, Hui Qiao

Hum Vaccin Immunother. 2022; 18(6): 2102354. Published online 2022 Aug 3. doi: 10.1080/21645515.2022.2102354

PMCID:: PMC9746390

Article PDF–718K

Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital

Piyarat Limpawittayakul, Prakongboon Sungkasubun, Worawit Chaiwiriyawong, Archara Supavavej, Bowon Weerasubpong, Jomtana Siripaibun, Chumut Phanthunane, Wisut Lamlertthon, Teerapat Ungtrakul, Kriangkrai Tawinprai, Walaipan Tantiyavarong, Chayanee Samdaengpan

Hum Vaccin Immunother. 2022; 18(6): 2104058. Published online 2022 Aug 17. doi: 10.1080/21645515.2022.2104058

PMCID:: PMC9746434

Article PDF–1.3M

Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia

Endeshaw Chekol Abebe, Teklie Mengie Ayele, Zelalem Tilahun Muche, Awgichew Behaile T/Mariam, Nega Dagnaw Baye, Melaku Mekonnen Agidew, Tadesse Asmamaw Dejenie

Hum Vaccin Immunother. 2022; 18(6): 2104059. Published online 2022 Aug 12. doi: 10.1080/21645515.2022.2104059

PMCID:: PMC9746497

Article PDF–741K

Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients

Yuki Higashimoto, Kei Kozawa, Hiroki Miura, Yoshiki Kawamura, Masaru Ihira, Hiroyuki Hiramatsu, Ryota Suzuki, Kei Haga, Reiko Takai-Todaka, Akihito Sawada, Kazuhiko Katayama, Tetsushi Yoshikawa

Hum Vaccin Immunother. 2022; 18(6): 2105611. Published online 2022 Sep 12. doi: 10.1080/21645515.2022.2105611

PMCID:: PMC9746447

Article PDF–531K

Adherence to and early adverse events of COVID-19 vaccine in a cohort of 600 Italian breastfeeding and pregnant physicians

Marco Montalti, Federica Guaraldi, Zeno Di Valerio, Benedetta Ragghianti, Dario Tedesco, Edoardo Mannucci, Matteo Monami, Davide Gori

Hum Vaccin Immunother. 2022; 18(6): 2106747. Published online 2022 Aug 9. doi: 10.1080/21645515.2022.2106747

PMCID:: PMC9746389

Article PDF–336K

The mediating role of product judgment and country of origin effect on health literacy and behavioral intention: A study on COVID-19 vaccines perception of Turkish consumers

Talha Bayır, Burhan Kılıç, Yakup Durmaz

Hum Vaccin Immunother. 2022; 18(6): 2107838. Published online 2022 Aug 5. doi: 10.1080/21645515.2022.2107838

PMCID:: PMC9750499

Article PDF–1.1M

A national platform for Covid-19 vaccine studies recruitment in France: Covireivac volunteer’s characteristics

Marion Bonneton, Jessica Sambourg, Liem Binh Luong Nguyen, Christine Trillou, Joyce Dohou, Olivier Saint Lary, Mathieu Schuers, Marie Lachâtre, Odile Launay

Hum Vaccin Immunother. 2022; 18(6): 2109364. Published online 2022 Aug 26. doi: 10.1080/21645515.2022.2109364

PMCID:: PMC9746455

Article PDF–350K

Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021

Nicole G. Morozov, Amiel A. Dror, Amani Daoud, Netanel Eisenbach, Edward Kaykov, Masad Barhoum, Tsvi Sheleg, Eyal Sela, Michael Edelstein

Hum Vaccin Immunother. 2022; 18(6): 2112879. Published online 2022 Aug 29. doi: 10.1080/21645515.2022.2112879

PMCID:: PMC9746408

Article PDF–414K

COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis

Getaneh Mulualem Belay, Tewodros Getaneh Alemu, Masresha Asmare Techane, Chalachew Adugna Wubneh, Nega Tezera Assimamaw, Tadesse Tarik Tamir, Addis Bilal Muhye, Destaye Guadie Kassie, Amare Wondim, Bewuketu Terefe, Bethlehem Tigabu Tarekegn, Mohammed Seid Ali, Beletech Fentie, Almaz Tefera Gonete, Berhan Tekeba, Selam Fisiha Kassa, Bogale Kassahun Desta, Amare Demsie Ayele, Melkamu Tilahun Dessie, Kendalem Asmare Atalell

Hum Vaccin Immunother. 2022; 18(6): 2114699. Published online 2022 Sep 12. doi: 10.1080/21645515.2022.2114699

PMCID:: PMC9746388

Article PDF–4.0M

Factors influencing COVID-19 vaccine decision-making among hesitant adopters in the United States

Rachel S. Purvis, Ramey Moore, Don E. Willis, Emily Hallgren, Pearl A. McElfish

Hum Vaccin Immunother. 2022; 18(6): 2114701. Published online 2022 Sep 7. doi: 10.1080/21645515.2022.2114701

PMCID:: PMC9746519

Article PDF–386K

Knowledge, attitudes, and behaviors toward COVID-19 vaccination in a sample of Italian healthcare workers

Luca Regazzi, Eleonora Marziali, Alberto Lontano, Leonardo Villani, Andrea Paladini, Giovanna Elisa Calabrò, Patrizia Laurenti, Walter Ricciardi, Chiara Cadeddu

Hum Vaccin Immunother. 2022; 18(6): 2116206. Published online 2022 Oct 5. doi: 10.1080/21645515.2022.2116206

PMCID:: PMC9746397

Article PDF–443K

Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination

Yimei Feng, Yao Quan, Kaniel Cassady, Zhongmin Zou, Yuan Gao, Xi Zhang

Hum Vaccin Immunother. 2022; 18(6): 2119043. Published online 2022 Sep 7. doi: 10.1080/21645515.2022.2119043

PMCID:: PMC9746405

Article PDF–1.1M

Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis

Juntao Yin, Yangyang Chen, Yang Li, Xingwang Zhang, Chaoyang Wang

Hum Vaccin Immunother. 2022; 18(6): 2119763. Published online 2022 Sep 26. doi: 10.1080/21645515.2022.2119763

PMCID:: PMC9746490

Article PDF–3.6M

Current status of coronavirus disease 2019 vaccine research based on bibliometric analysis

Peiling Gan, Xiao Pan, Shu Huang, Huifang Xia, Xian Zhou, Xiaowei Tang

Hum Vaccin Immunother. 2022; 18(6): 2119766. Published online 2022 Sep 15. doi: 10.1080/21645515.2022.2119766

PMCID:: PMC9746459

Article PDF–5.2M

Parental perceptions of the COVID-19 vaccine for 5- to 11-year-old children: Focus group findings from Worcester Massachusetts

Melissa Goulding, Grace W. Ryan, Princilla Minkah, Amy Borg, Maricelis Gonzalez, Nelly Medina, Pamela Suprenant, Milagros C. Rosal, Stephenie C. Lemon

Hum Vaccin Immunother. 2022; 18(6): 2120721. Published online 2022 Sep 9. doi: 10.1080/21645515.2022.2120721

PMCID:: PMC9746412

Article PDF–358K

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

Ahmet Omma, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Güven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ates Kara, Ihsan Ates

Hum Vaccin Immunother. 2022; 18(6): 2122503. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2122503

PMCID:: PMC9746394

Article PDF–2.8M

Attitudes of healthcare workers and members of the public toward the COVID-19 vaccine: A cross-sectional survey

Shira Ramot, Orna Tal

Hum Vaccin Immunother. 2022; 18(6): 2124782. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2124782

PMCID:: PMC9746361

Article PDF–404K

Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China

Yulan Lin, Zhiwen Huang, Xiaonan Xu, Wei Du, Haridah Alias, Zhijian Hu, Li Ping Wong

Hum Vaccin Immunother. 2022; 18(6): 2126667. Published online 2022 Sep 27. doi: 10.1080/21645515.2022.2126667

PMCID:: PMC9746437

Article PDF–1.9M

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Results from an active pharmacovigilance study in central Italy

Giancarlo Ripabelli, Michela Lucia Sammarco, Antonio D’Amico, Roberta De Dona, Mariagrazia Iafigliola, Albino Parente, Nicandro Samprati, Arturo Santagata, Carmen Adesso, Anna Natale, Michela Anna Di Palma, Fabio Cannizzaro, Roberto Romano, Antonietta Licianci, Manuela Tamburro

Hum Vaccin Immunother. 2022; 18(6): 2126668. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2126668

PMCID:: PMC9746364

Article PDF–342K

A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts

Michael D. Schultz, John J. Suschak, Davide Botta, Aaron Silva-Sanchez, R. Glenn King, Thomas W. Detchemendy, Chetan D. Meshram, Jeremy B. Foote, Fen Zhou, Jennifer L. Tipper, Jianfeng Zhang, Kevin S. Harrod, Sixto M. Leal, Jr, Troy D. Randall, M. Scot Roberts, Bertrand Georges, Frances E. Lund

Hum Vaccin Immunother. 2022; 18(6): 2127292. Published online 2022 Oct 4. doi: 10.1080/21645515.2022.2127292

PMCID:: PMC9746417

Article PDF–5.4M

Lack of clear national policy guidance on COVID-19 vaccines influences behaviors in pregnant and lactating women in Kenya

Eleonor Zavala, Berhaun Fesshaye, Clarice Lee, Stephen Mutwiwa, Wincate Njagi, Paul Munyao, Rosemary Njogu, Rachel Gur-Arie, Alicia M. Paul, Taylor A. Holroyd, Prachi Singh, Ruth A. Karron, Rupali J. Limaye

Hum Vaccin Immunother. 2022; 18(6): 2127561. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2127561

PMCID:: PMC9746464

Article PDF–629K

Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health records

Columbus Ohaeri, Daniel Rhys Thomas, Jane Salmon, Simon Cottrell, Jane Lyons, Ashley Akbari, Ronan A Lyons, Fatemeh Torabi, Gareth GI Davies, Christopher Williams

Hum Vaccin Immunother. 2022; 18(6): 2127572. Published online 2022 Oct 27. doi: 10.1080/21645515.2022.2127572

PMCID:: PMC9746546

Article PDF–3.0M

Barriers and facilitators to the future uptake of regular COVID-19 booster vaccinations among young adults in the UK

Lynn Williams, Allyson Gallant, Lily Brown, Kathleen Corrigan, Katrina Crowe, Emma Hendry

Hum Vaccin Immunother. 2022; 18(6): 2129238. Published online 2022 Oct 4. doi: 10.1080/21645515.2022.2129238

PMCID:: PMC9746469

Article PDF–336K

A qualitative investigation of facilitators and barriers to accessing COVID-19 vaccines among Racialized and Indigenous Peoples in Canada

Laura Aylsworth, Terra Manca, Ève Dubé, Fabienne Labbé, S. Michelle Driedger, Karen Benzies, Noni MacDonald, Janice Graham, Shannon E. MacDonald

Hum Vaccin Immunother. 2022; 18(6): 2129827. Published online 2022 Oct 11. doi: 10.1080/21645515.2022.2129827

PMCID:: PMC9746392

Article PDF–333K

I have decided about my COVID-19 vaccine, what about my child?

Shlomit Hon Snir, Sharon Teitler Regev

Hum Vaccin Immunother. 2022; 18(6): 2129929. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2129929

PMCID:: PMC9746399

Article PDF–331K

Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study

Mohamed H. Elbadawi, Lina S. Altayib, Anmar Birier Gadallah Birier, Laila E. Ali, Elfatih A. Hasabo, Mariam Alazraa M. Esmaeel, Osman K. Elmahi, Group of collaborators

Hum Vaccin Immunother. 2022; 18(6): 2132082. Published online 2022 Nov 18. doi: 10.1080/21645515.2022.2132082

PMCID:: PMC9746377

Article PDF–325K

Understanding motivations and deterrents for COVID-19 vaccination among US working adults: A mixed method approach

Seulki Rachel Jang, Sun Kyong Lee, Shane Connelly

Hum Vaccin Immunother. 2022; 18(6): 2132752. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2132752

PMCID:: PMC9746545

Article PDF–376K

COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance database

Basile Chrétien, Rhéda Stroiazzo, Leila Troussier, Pierre-Yves Le Houssel, Magali Jacquet, Cécile Lheureux, Sandy Voyen, Philippe Court, Charles Dolladille, Joachim Alexandre, Sophie Fedrizzi, Xavier Humbert

Hum Vaccin Immunother. 2022; 18(6): 2135918. Published online 2022 Nov 9. doi: 10.1080/21645515.2022.2135918

PMCID:: PMC9746357

Article PDF–330K

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial

Dandan Zhu, Yuansheng Hu, Zhiwei Jiang, Tuantuan Yang, Kai Chu, Hengming Zhang, Jialei Hu, Xing Meng, Zhijun Tan, Jingliang Wu, Xiaojuan Lian, Changgui Li, Hongxing Pan

Hum Vaccin Immunother. 2022; 18(6): 2135929. Published online 2022 Nov 28. doi: 10.1080/21645515.2022.2135929

PMCID:: PMC9746504

Article PDF–323K

Adverse reactions to inactivated COVID-19 vaccination in patients with chronic liver disease: The effect of anxiety

Li Lv, Xiao-Qing Lin, Yan Chen, He-Dan Chen, Mei-Xian Zhang, Hui Shao, Tao-Hsin Tung, Jian-Sheng Zhu

Hum Vaccin Immunother. 2022; 18(6): 2136435. Published online 2022 Oct 26. doi: 10.1080/21645515.2022.2136435

PMCID:: PMC9746530

Article PDF–233K

Inflammatory ocular events after inactivated COVID-19 vaccination

Ping Fei, Huazhang Feng, Jing Li, Miaomiao Liu, Jia Luo, Hongfei Ye, Peiquan Zhao

Hum Vaccin Immunother. 2022; 18(6): 2138051. Published online 2022 Nov 11. doi: 10.1080/21645515.2022.2138051

PMCID:: PMC9746467

Article PDF–1.9M

Determinants of the willingness of medical staff to vaccinate their children with a booster dose of the COVID-19 vaccine in Taizhou, China

Li-Li Huang, Tao-Hsin Tung, Yan-Hong Jiang, Wei-Wei Hu, Yu-Pei Yang

Hum Vaccin Immunother. 2022; 18(6): 2139098. Published online 2022 Nov 28. doi: 10.1080/21645515.2022.2139098

PMCID:: PMC9746360

Article PDF–507K

Neighborhood social cohesion is associated with the willingness toward the booster dose of COVID-19 vaccines among the Chinese older population

Chenyuan Qin, Qiao Liu, Min Du, Wenxin Yan, Liyuan Tao, Yaping Wang, Min Liu, Jue Liu

Hum Vaccin Immunother. 2022; 18(6): 2140530. Published online 2022 Nov 14. doi: 10.1080/21645515.2022.2140530

PMCID:: PMC9746548

Article PDF–1.2M

Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study

Kei Nakashima, Masayuki Ishida, Hiroki Matsui, Chihiro Yoshida, Tatsuya Nagai, Minoru Shiraga, Hiroshi Nakaoka, Yoshihito Otsuka, Yu Nakagama, Natsuko Kaku, Yuko Nitahara, Yasutoshi Kido, Yoshio Hirota

Hum Vaccin Immunother. 2022; 18(6): 2140549. Published online 2022 Nov 11. doi: 10.1080/21645515.2022.2140549

PMCID:: PMC9746471

Article PDF–2.0M

The effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: A clinical observation in China

Aizhen Huang, Yanting Lu, Jingjing Ji, Yankun Yao, Shiping Guan, Zirong Chen, Lu Yu

Hum Vaccin Immunother. 2022; 18(6): 2141519. Published online 2022 Nov 22. doi: 10.1080/21645515.2022.2141519

PMCID:: PMC9746452

Article PDF–783K

Healthcare workers’ attitudes on mandates, incentives, and strategies to improve COVID-19 vaccine uptake: A mixed methods study

Sharon M. Casey, Shana A. B. Burrowes, Taylor Hall, Sidney Dobbins, Mengyu Ma, Ruqiyya Bano, Christina Yarrington, Elissa M. Schechter-Perkins, Christopher Garofalo, Mari-Lynn Drainoni, Rebecca B. Perkins, Natalie Pierre-Joseph

Hum Vaccin Immunother. 2022; 18(6): 2144048. Published online 2022 Nov 21. doi: 10.1080/21645515.2022.2144048

PMCID:: PMC9746602

Article PDF–498K

Post-vaccination adverse reactions, decision regret, and willingness to pay for the booster dose of COVID-19 vaccine among healthcare workers: A mediation analysis

Chengwen Luo, Weicong Jiang, Hai-Xiao Chen, Tao-Hsin Tung

Hum Vaccin Immunother. 2022; 18(6): 2146964. Published online 2022 Nov 24. doi: 10.1080/21645515.2022.2146964

PMCID:: PMC9746528

Article PDF–547K

Coronavirus – Research Paper

Factors influencing parents’ willingness to vaccinate their preschool children against COVID-19: Results from the mixed-method study in China

Mengmou Zheng, Wanzhen Zhong, Xiyue Chen, Nan Wang, Yadan Liu, Qian Zhang, Yaoyilian Cheng, Wen Li, Qiong Yu, Xunying Zhao, Lu Yuan, Ziqiong Shen, Yu Hao, Yu Du, Kun Zou, Chenyan Zhu, Lu Long, Jiayuan Li

Hum Vaccin Immunother. 2022; 18(6): 2090776. Published online 2022 Jun 28. doi: 10.1080/21645515.2022.2090776

PMCID:: PMC9746380

Article PDF–465K

Message testing in India for COVID-19 vaccine uptake: What appeal and what messenger are most persuasive?

Rupali J. Limaye, Daniel J. Erchick, Kristian Balgobin, Alexandra Michel, Gretchen Schulz

Hum Vaccin Immunother. 2022; 18(6): 2091864. Published online 2022 Jul 13. doi: 10.1080/21645515.2022.2091864

PMCID:: PMC9746414

Article PDF–5.5M

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan, Sompong Sapsutthipas, Yuparat Jantraphakorn, Natthakarn Mingngamsup, Paul V Licciardi, Kulkanya Chokephaibulkit

Hum Vaccin Immunother. 2022; 18(6): 2091865. Published online 2022 Jul 11. doi: 10.1080/21645515.2022.2091865

PMCID:: PMC9746495

Article PDF–4.9M

Group-based trajectory modeling to identify health beliefs of COVID-19 vaccination and its predictors: A cohort study in China

Linlin Kang, Yanjiao Wang, Sizhong Xing, Hang Li, Ching-Wen Chien, Tao-Hsin Tung

Hum Vaccin Immunother. 2022; 18(6): 2091899. Published online 2022 Aug 17. doi: 10.1080/21645515.2022.2091899

PMCID:: PMC9746605

Article PDF–2.1M

A community-based study in the central district of Giresun: COVID-19 vaccine hesitancy

Asli Ata Teneler, Fatma Ayhan, Emrah Zaim, Unal Ozek

Hum Vaccin Immunother. 2022; 18(6): 2092362. Published online 2022 Jul 7. doi: 10.1080/21645515.2022.2092362

PMCID:: PMC9746411

Article PDF–343K

Nussara Pakvisal, Panot Sainamthip, Nattaya Teeyapun, Sutima Luangdilok, Nassamon Wanlapakorn, Ritthideach Yorsaeng, Yong Poovorawan, Piyapoom Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn, Virote Sriuranpong, Suebpong Tanasanvimon, Passakorn Wanchaijiraboon

Hum Vaccin Immunother. 2022; 18(6): 2094149. Published online 2022 Jul 1. doi: 10.1080/21645515.2022.2094149

PMCID:: PMC9746493

Article PDF–4.7M

Knowledge, perception, and acceptance toward the booster dose of COVID-19 vaccine among patients visiting dental clinics in Aseer region of KSA

Shahabe Saquib Abullais, Suraj Arora, Meelaf Al Shahrani, Abdul Ahad Khan, Waleed Al Shahrani, Syed Esam Mahmood, Saad Al Qahtani, Mohammed Maqbool, Ahmad Saib Jameel, Priyanka Saluja

Hum Vaccin Immunother. 2022; 18(6): 2095162. Published online 2022 Jul 20. doi: 10.1080/21645515.2022.2095162

PMCID:: PMC9746421

Article PDF–1.1M

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China

Tao-Hsin Tung, Xiao-Qing Lin, Yan Chen, Mei-Xian Zhang, Jian-Sheng Zhu

Hum Vaccin Immunother. 2022; 18(6): 2099210. Published online 2022 Jul 26. doi: 10.1080/21645515.2022.2099210

PMCID:: PMC9746460

Article PDF–410K

Coronavirus – Review

COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature

Muath A. Alsalloum, Yusuf M. Garwan, Jimmy Jose, Abrar K. Thabit, Nour Baghdady

Hum Vaccin Immunother. 2022; 18(6): 2091898. Published online 2022 Jun 29. doi: 10.1080/21645515.2022.2091898

PMCID:: PMC9746509

Article PDF–446K

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2

Lairun Jin, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Fengcai Zhu

Hum Vaccin Immunother. 2022; 18(6): 2096970. Published online 2022 Jul 25. doi: 10.1080/21645515.2022.2096970

PMCID:: PMC9746539

Article PDF–1.0M

Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess

Peter Yamoah, Kofi Boamah Mensah, Joseph Attakorah, Neelaveni Padayachee, Frasia Oosthuizen, Varsha Bangalee

Hum Vaccin Immunother. 2022; 18(6): 2109365. Published online 2022 Aug 10. doi: 10.1080/21645515.2022.2109365

PMCID:: PMC9897635

Article PDF–243K

Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies

Cécile Janssen, Anne Mosnier, Gaëtan Gavazzi, Behazine Combadière, Pascal Crépey, Jacques Gaillat, Odile Launay, Elisabeth Botelho-Nevers

Hum Vaccin Immunother. 2022; 18(6): 2131166. Published online 2022 Oct 18. doi: 10.1080/21645515.2022.2131166

PMCID:: PMC9746457

Article PDF–2.5M

Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature”

Lauren Tostrud, Julia Thelen, Anna Palatnik

Hum Vaccin Immunother. 2022; 18(6): 2138047. Published online 2022 Nov 7. doi: 10.1080/21645515.2022.2138047

PMCID:: PMC9746492

Article PDF–938K

Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis

Patrick D. M. C. Katoto, Amanda S. Brand, Liliane N. Byamungu, Jacques L. Tamuzi, Tamirirashe C. Mahwire, Marcel K. Kitenge, Charles S. Wiysonge, Glenda Gray

Hum Vaccin Immunother. 2022; 18(6): 2144039. Published online 2022 Nov 11. doi: 10.1080/21645515.2022.2144039

PMCID:: PMC9746476

Article PDF–22M

Coronavirus – Short Report

Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open question

Pasquale Stefanizzi, Silvio Tafuri, Francesco Paolo Bianchi

Hum Vaccin Immunother. 2022; 18(6): 2094653. Published online 2022 Jul 12. doi: 10.1080/21645515.2022.2094653

PMCID:: PMC9746376

Article PDF–219K

HPV – Article Commentary

Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9

Sean T. O’Leary

Hum Vaccin Immunother. 2022; 18(6): 2146434. Published online 2022 Nov 20. doi: 10.1080/21645515.2022.2146434

PMCID:: PMC9746363

Article PDF–205K

HPV – Brief Report

HPV vaccination and HIV preexposure prophylaxis (PrEP): Missed opportunities for anal cancer prevention among at risk populations

Christopher W. Wheldon

Hum Vaccin Immunother. 2022; 18(6): 2114258. Published online 2022 Aug 26. doi: 10.1080/21645515.2022.2114258

PMCID:: PMC9746506

Article PDF–330K

HPV – Commentary

Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program

Mugen Ujiie

Hum Vaccin Immunother. 2022; 18(6): 2090777. Published online 2022 Jun 29. doi: 10.1080/21645515.2022.2090777

PMCID:: PMC9746481

Article PDF–160K

HPV – Research Article

Evaluating the quality of HPV vaccine-related information on the Portuguese Internet

Michael Zarnowski Passos, Agnaldo Lopes da Silva-Filho, Wladmir Cardoso Brandão, Mariana Furtado Meinberg, Rogéria Andrade Werneck

Hum Vaccin Immunother. 2022; 18(6): 2104571. Published online 2022 Jul 26. doi: 10.1080/21645515.2022.2104571

PMCID:: PMC9746425

Article PDF–1.0M

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants

Suzanne M. Garland, Manjula Anagani, Neerja Bhatla, Sukanta Chatterjee, Sanjay Lalwani, Cecil Ross, Thomas Group, Jianxin Lin, Alain Luxembourg, Anuj Walia, Yingmei Tu

Hum Vaccin Immunother. 2022; 18(6): 2105067. Published online 2022 Aug 23. doi: 10.1080/21645515.2022.2105067

PMCID:: PMC9746475

Article PDF–440K

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer

Eric Y. Du, Eric Adjei Boakye, Derian B. Taylor, Duaa Kuziez, Rebecca L. Rohde, Jaibir S. Pannu, Matthew C. Simpson, Rolvix H. Patterson, Mark A. Varvares, Nosayaba Osazuwa-Peters

Hum Vaccin Immunother. 2022; 18(6): 2109892. Published online 2022 Sep 7. doi: 10.1080/21645515.2022.2109892

PMCID:: PMC9746525

Article PDF–335K

Effects of a web-based HPV vaccination intervention on cognitive outcomes among young gay, bisexual, and other men who have sex with men

Paul L. Reiter, Amy L. Gower, Dale E. Kiss, Abigail B. Shoben, Mira L. Katz, José A. Bauermeister, Electra D. Paskett, Annie-Laurie McRee

Hum Vaccin Immunother. 2022; 18(6): 2114261. Published online 2022 Sep 7. doi: 10.1080/21645515.2022.2114261

PMCID:: PMC9746382

Article PDF–345K

Awareness and acceptance of HPV vaccination for condyloma acuminata among men who have sex with men in China

Xuqi Ren, Lingxian Qiu, Wujian Ke, Huachun Zou, Anqi Liu, Ting Wu

Hum Vaccin Immunother. 2022; 18(6): 2115267. Published online 2022 Sep 13. doi: 10.1080/21645515.2022.2115267

PMCID:: PMC9746430

Article PDF–413K

HPV vaccine intention among university students during suspension of active recommendation in Japan

Tomoya Suzuki, Yu Ota, Natsuya Sakata, Nozomi Fujita, Makoto Kamatsuka, Kengo Nagashima, Junko Hirayama, Naoko Fujita, Kuniko Shiga, Noriaki Oyama, Yukihiro Terada, Kyoko Nomura

Hum Vaccin Immunother. 2022; 18(6): 2116900. Published online 2022 Sep 15. doi: 10.1080/21645515.2022.2116900

PMCID:: PMC9746521

Article PDF–569K

Stated preferences for human papillomavirus vaccination for adolescents in selected communities in Ibadan, Southwest Nigeria: A discrete choice experiment

Folusho M. Balogun, Olayemi O. Omotade, Mikael Svensson

Hum Vaccin Immunother. 2022; 18(6): 2124091. Published online 2022 Nov 16. doi: 10.1080/21645515.2022.2124091

PMCID:: PMC9746423

Article PDF–355K

Willingness to accept human papillomavirus vaccination in Jimma town, Ethiopia

Tsegaw Biyazin, Aynalem Yetwale, Belete Fenta

Hum Vaccin Immunother. 2022; 18(6): 2125701. Published online 2022 Sep 26. doi: 10.1080/21645515.2022.2125701

PMCID:: PMC9746436

Article PDF–628K

Factors affecting children’s HPV vaccination in Austria: Evidence from a parent survey

Madeleine Waser, Raffael Heiss, Wegene Borena

Hum Vaccin Immunother. 2022; 18(6): 2126251. Published online 2022 Oct 17. doi: 10.1080/21645515.2022.2126251

PMCID:: PMC9746446

Article PDF–406K

Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain

Renata Linertová, Carmen Guirado-Fuentes, Javier Mar-Medina, Conor Teljeur

Hum Vaccin Immunother. 2022; 18(6): 2127983. Published online 2022 Nov 8. doi: 10.1080/21645515.2022.2127983

PMCID:: PMC9746431

Article PDF–953K

Survey of pediatricians concerning the human papillomavirus vaccine in Japan: Positive attitudes toward vaccination during the period of proactive recommendation being withheld

Megumi Kubota, Kyoko Kondo, Yasuo Tomiyoshi, Wakaba Fukushima

Hum Vaccin Immunother. 2022; 18(6): 2131337. Published online 2022 Oct 27. doi: 10.1080/21645515.2022.2131337

PMCID:: PMC9746366

Article PDF–300K

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination

Ikponmwosa Osaghae, Charles Darkoh, Onyema Greg Chido-Amajuoyi, Wenyaw Chan, Paige Padgett Wermuth, Mala Pande, Sonia a Cunningham, Sanjay Shete

Hum Vaccin Immunother. 2022; 18(6): 2132755. Published online 2022 Oct 20. doi: 10.1080/21645515.2022.2132755

PMCID:: PMC9746413

Article PDF–393K

Discrepancy of human papillomavirus vaccine uptake and intent between girls 9–14 and their mothers in a pilot region of Shanghai, China

Qi Guo, Weiyu Zhou, Xiaosa Wen, Jia Lu, Xinyu Lu, Yihan Lu

Hum Vaccin Immunother. 2022; 18(6): 2132801. Published online 2022 Oct 28. doi: 10.1080/21645515.2022.2132801

PMCID:: PMC9746362

Article PDF–885K

Human papillomavirus vaccinations at recommended ages: How a middle school-based educational and vaccination program increased uptake in the Rio Grande Valley

Ana M. Rodriguez, Thuy Quynh N. Do, Lu Chen, Kathleen M. Schmeler, Jane R. Montealegre, Yong-Fang Kuo

Hum Vaccin Immunother. 2022; 18(6): 2133315. Published online 2022 Oct 17. doi: 10.1080/21645515.2022.2133315

PMCID:: PMC9746445

Article PDF–290K

Health literacy and its association with human papilloma virus vaccination among adults: Findings from the behavioral risk factor surveillance system

Vinodh Bhoopathi, Pradeep Bhagavatula, Maharaj Singh

Hum Vaccin Immunother. 2022; 18(6): 2135930. Published online 2022 Oct 27. doi: 10.1080/21645515.2022.2135930

PMCID:: PMC9746451

Article PDF–336K

An opportunity to increase human papillomavirus vaccination rates: Change the guidelines

Abraham Aragones, Francesca Gany, Andrea Kaplan, Denise Bruno

Hum Vaccin Immunother. 2022; 18(6): 2136444. Published online 2022 Oct 25. doi: 10.1080/21645515.2022.2136444

PMCID:: PMC9746429

Article PDF–269K

Healthcare providers’ practice protocols, strategies, and needed tools to address parental HPV vaccine hesitancy: An exploratory study

Jennifer Cunningham-Erves, Pamela C. Hull, Consuelo H. Wilkins, Kathryn M. Edwards, Megan Davis, Jessica Jones, Jenee Graham, Abiola Adekunle, Amanda F. Dempsey

Hum Vaccin Immunother. 2022; 18(6): 2136862. Published online 2022 Nov 14. doi: 10.1080/21645515.2022.2136862

PMCID:: PMC9746367

Article PDF–1.3M

HPV – Research Paper

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial

Zhao-Jun Mo, Zhao-Feng Bi, Wei Sheng, Qi Chen, Teng Huang, Ming-Qiang Li, Xue-Lian Cui, Ya-Hui Wangjiang, Bi-Zhen Lin, Feng-Zhu Zheng, Guang Sun, Ya-Fei Li, Ya Zheng, Si-Jie Zhuang, Ying-Ying Su, Hui-Rong Pan, Shou-Jie Huang, Ting Wu, Jun Zhang, Ning-Shao Xia

Hum Vaccin Immunother. 2022; 18(6): 2092363. Published online 2022 Jul 14. doi: 10.1080/21645515.2022.2092363

PMCID:: PMC9746527

Article PDF–1.6M

HPV – Review

Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach

Finlay Pilcher, Jan Kirk Carney, Gary S. Stein

Hum Vaccin Immunother. 2022; 18(6): 2122494. Published online 2022 Sep 21. doi: 10.1080/21645515.2022.2122494

PMCID:: PMC9746368

Article PDF–3.0M

Hepatitis – Research Article

A community-wide epidemic of hepatitis A virus genotype IA associated with consumption of shellfish in Yantai, eastern China, January to March 2020

Bingyu Yan, Peng Chen, Yi Feng, Jingjing Lu, Xin Meng, Qing Xu, Aiqiang Xu, Li Zhang

Hum Vaccin Immunother. 2022; 18(6): 2106081. Published online 2022 Aug 15. doi: 10.1080/21645515.2022.2106081

PMCID:: PMC9746409

Article PDF–1.5M

Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices

Oscar Herrera-Restrepo, Kimberly Davis, Carolyn Sweeney, Eric Davenport, Parinaz Ghaswalla, Philip O. Buck

Hum Vaccin Immunother. 2022; 18(6): 2123180. Published online 2022 Oct 26. doi: 10.1080/21645515.2022.2123180

PMCID:: PMC9746442

Article PDF–2.9M

Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study

Matthias Girndt, Manfred Plüer, Frank Dellanna, Ann K. Michelsen, Joachim Beige, Kai Toussaint, Hubert J. Wehweck, Michael Koch, Syrus Hafezi Rachti, Justus Faust, Hans-Peter Bosselmann, Oliver Witzke, Robert S. Janssen, the HBV-18 Study Investigators

Hum Vaccin Immunother. 2022; 18(6): 2136912. Published online 2022 Oct 21. doi: 10.1080/21645515.2022.2136912

PMCID:: PMC9746491

Article PDF–407K

Immunotherapeutics – Case Report

Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case

Taowei Wu, Faya Liang, Peiliang Lin, Yangyang Li, Xiaoming Huang, Ping Han

Hum Vaccin Immunother. 2022; 18(6): 2093075. Published online 2022 Jul 25. doi: 10.1080/21645515.2022.2093075

PMCID:: PMC9746516

Article PDF–5.1M

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report

Wei-Ling Li, Ying Zhang, Xiao-Ling Zhang, Yun-Yi Du, Wen-Qing Hu, Jun Zhao

Hum Vaccin Immunother. 2022; 18(6): 2121109. Published online 2022 Sep 27. doi: 10.1080/21645515.2022.2121109

PMCID:: PMC9746372

Article PDF–1.9M

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report

YunYi Du, XiaoLing Zhang, Ying Zhang, WeiLing Li, WenQing Hu, Liang Zong, Jun Zhao

Hum Vaccin Immunother. 2022; 18(6): 2121122. Published online 2022 Sep 26. doi: 10.1080/21645515.2022.2121122

PMCID:: PMC9746458

Article PDF–4.2M

Immunotherapeutics – Meeting Report

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy

Peer Andre Berger, Janina Freitag, Sophie-Christin Linkenbach, Lukas Merz, Maik Schork, Sophia Thevissen, Ikra Yildiz, Jan D. Beck

Hum Vaccin Immunother. 2022; 18(6): 2124785. Published online 2022 Oct 12. doi: 10.1080/21645515.2022.2124785

PMCID:: PMC9746370

Article PDF–347K

Immunotherapeutics – Mini-Review

Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses

Qiliang Yin, Ying Wang, Yipeng Xiang, Feng Xu

Hum Vaccin Immunother. 2022; 18(6): 2119020. Published online 2022 Sep 28. doi: 10.1080/21645515.2022.2119020

PMCID:: PMC9746515

Article PDF–3.3M

Immunotherapeutics – Research Article

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study

Susanna Esposito, Michele Cassano, Renato Cutrera, Francesco Menzella, Alfonso Varricchio, Marzio Uberti

Hum Vaccin Immunother. 2022; 18(6): 2106720. Published online 2022 Aug 19. doi: 10.1080/21645515.2022.2106720

PMCID:: PMC9746428

Article PDF–306K

Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype

C. Riccay Elizondo, Jennifer D. Bright, Robert K. Bright

Hum Vaccin Immunother. 2022; 18(6): 2108656. Published online 2022 Sep 7. doi: 10.1080/21645515.2022.2108656

PMCID:: PMC9746449

Article PDF–5.3M

Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development

Dustin Hicks, Carly Baehr, Pedro Silva-Ortiz, Aaron Khaimraj, Diego Luengas, Fatima A. Hamid, Marco Pravetoni

Hum Vaccin Immunother. 2022; 18(6): 2122507. Published online 2022 Oct 4. doi: 10.1080/21645515.2022.2122507

PMCID:: PMC9746415

Article PDF–2.9M

Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count

Charles-Antoine Coupet, Clarisse Dubois, Alexeï Evlachev, Nadine Kehrer, Marie Baldazza, Sam Hofman, Michel Vierboom, Perrine Martin, Geneviève Inchauspe

Hum Vaccin Immunother. 2022; 18(6): 2133914. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2133914

PMCID:: PMC9746448

Article PDF–4.7M

Elizabeth R. Packnett, Isabelle H. Winer, Heather Larkin, Abiola Oladapo, Tara Gonzales, Matthew Wojdyla, Mitchell Goldstein, Vincent C. Smith

Hum Vaccin Immunother. 2022; 18(6): 2140533. Published online 2022 Nov 22. doi: 10.1080/21645515.2022.2140533

PMCID:: PMC9746385

Article PDF–423K

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort

Xiaoling Gong, Yahui Zhu, Qianning Zhang, Xin Qiu, Changchang Lu, Fan Tong, Qiaoli Wang, Weiwei Kong, Haihui Zhou, Baorui Liu, Yujie Zhou, Juan Du

Hum Vaccin Immunother. 2022; 18(6): 2143154. Published online 2022 Nov 22. doi: 10.1080/21645515.2022.2143154

PMCID:: PMC9746550

Article PDF–2.9M

Immunotherapeutics – Research Paper

Waning of maternal antibody against measles virus in Shufu, China

Qing He, Shujun Fan, Zhenxiang Xue, Jun Yuan, Yuzhong Wang, Zhicong Yang, Ziyan Zhou, Zhoubin Zhang

Hum Vaccin Immunother. 2022; 18(6): 2045854. Published online 2022 Nov 18. doi: 10.1080/21645515.2022.2045854

PMCID:: PMC9746379

Article PDF–335K

Immunotherapeutics – Review

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

Tadesse Asmamaw Dejenie, Markeshaw Tiruneh G/Medhin, Gashaw Dessie Terefe, Fitalew Tadele Admasu, Wondwossen Wale Tesega, Endeshaw Chekol Abebe

Hum Vaccin Immunother. 2022; 18(6): 2114254. Published online 2022 Sep 12. doi: 10.1080/21645515.2022.2114254

PMCID:: PMC9746433

Article PDF–1.4M

Review of bimekizumab in the treatment of psoriasis

Sindhuja Koppu, Rohan Singh, Kiranjit Kaur, Steven R. Feldman

Hum Vaccin Immunother. 2022; 18(6): 2119767. Published online 2022 Sep 12. doi: 10.1080/21645515.2022.2119767

PMCID:: PMC9746354

Article PDF–348K

Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity

Roberto Scendoni, Emanuele Bury, Isabella Lima Arrais Ribeiro, Roberto Cameriere, Mariano Cingolani

Hum Vaccin Immunother. 2022; 18(6): 2140552. Published online 2022 Nov 9. doi: 10.1080/21645515.2022.2140552

PMCID:: PMC9746524

Article PDF–2.4M

Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives

Yusuke Nagata, Shun Yamamoto, Ken Kato

Hum Vaccin Immunother. 2022; 18(6): 2143177. Published online 2022 Nov 14. doi: 10.1080/21645515.2022.2143177

PMCID:: PMC9746438

Article PDF–1.1M

The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies

Qiaoyun Ling, Bichun Zheng, Xudong Chen, Shaoshun Ye, Quan Cheng

Hum Vaccin Immunother. 2022; 18(6): 2143698. Published online 2022 Nov 11. doi: 10.1080/21645515.2022.2143698

PMCID:: PMC9746450

Article PDF–723K

Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases

Chunting Hua, Siji Chen, Hao Cheng

Hum Vaccin Immunother. 2022; 18(6): 2144667. Published online 2022 Nov 16. doi: 10.1080/21645515.2022.2144667

Correction in:: Hum Vaccin Immunother. 2023; 19(1): 2203053.

PMCID:: PMC9746473

Article PDF–1.5M

Immunotherapeutics – Short Report

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis

Andrzej Bozek, Renata Kozłowska, Maciej Misiołek, Wojciech Ścierski, Radosław Gawlik

Hum Vaccin Immunother. 2022; 18(6): 2097818. Published online 2022 Jul 11. doi: 10.1080/21645515.2022.2097818

PMCID:: PMC9746402

Article PDF–249K

Influenza – Article Commentary

Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return

Litjen J. Tan, Syed Ahmed, Mitchel C. Rothholz, George Kassianos, Jonathan S. Nguyen-Van-Tam

Hum Vaccin Immunother. 2022; 18(6): 2125754. Published online 2022 Sep 26. doi: 10.1080/21645515.2022.2125754

PMCID:: PMC9746353

Article PDF–206K

Influenza – Brief Report

Effectiveness of influenza vaccination on in-hospital death in older adults with respiratory diseases

Ruosu Zhang, Yuanjie Pang, Shiyu Wan, Ming Lu, Min Lv, Jiang Wu, Yangmu Huang

Hum Vaccin Immunother. 2022; 18(6): 2117967. Published online 2022 Sep 12. doi: 10.1080/21645515.2022.2117967

PMCID:: PMC9746403

Article PDF–471K

Influenza – Letter

Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years

J. Kevin Yin, Stephanie Pepin, Robertus van Aalst, Matthew M. Loiacono, Sandrine I. Samson

Hum Vaccin Immunother. 2022; 18(6): 2106749. Published online 2022 Aug 1. doi: 10.1080/21645515.2022.2106749

PMCID:: PMC9750711

Article PDF–211K

Influenza – Research Article

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India

Nijalingappa K. Kalappanavar, Apurba Ghosh, Monika Sharma, Latha Ravichandran, Nirmal Choraria, Saravanan P, Madhukar Pandey, Pradeep N, Prachee Shah, Sneha Nair, Ashfaque Shaikh, Serge van de Witte

Hum Vaccin Immunother. 2022; 18(6): 2104527. Published online 2022 Sep 2. doi: 10.1080/21645515.2022.2104527

PMCID:: PMC9746468

Article PDF–1.1M

The effectiveness of influenza vaccine among elderly Chinese: A regression discontinuity design based on Yinzhou regional health information platform

Guangxu Liu, Zhike Liu, Houyu Zhao, Yexiang Sun, Peng Shen, Hongbo Lin, Siyan Zhan

Hum Vaccin Immunother. 2022; 18(6): 2115751. Published online 2022 Oct 27. doi: 10.1080/21645515.2022.2115751

PMCID:: PMC9746462

Article PDF–1.1M

Factors influencing the decision to receive seasonal influenza vaccination among US corporate non-healthcare workers

Obianuju Genevieve Aguolu, Kathryn Willebrand, Jad A. Elharake, Hanya M. Qureshi, Moses Chapa Kiti, Carol Y. Liu, Ana Restrepo Mesa, Kristin Nelson, Samuel Jenness, Alessia Melegaro, Faruque Ahmed, Inci Yildirim, Fauzia A. Malik, Benjamin Lopman, Saad B. Omer

Hum Vaccin Immunother. 2022; 18(6): 2122379. Published online 2022 Sep 22. doi: 10.1080/21645515.2022.2122379

PMCID:: PMC9746537

Article PDF–2.8M

Anamnestic broadly reactive antibodies induced by H7N9 virus more efficiently bind to seasonal H3N2 strains

Yao Chen, Shannon P. Hilchey, Jiong Wang, Jessica Garigen, Martin S. Zand, Junqiong Huang

Hum Vaccin Immunother. 2022; 18(6): 2128014. Published online 2022 Oct 5. doi: 10.1080/21645515.2022.2128014

PMCID:: PMC9746487

Article PDF–3.6M

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies

Xiaoqiang Liu, Juliana Park, Shengli Xia, Bin Liang, Shuangmin Yang, Yanxia Wang, Olga Syrkina, Nathalie Lavis, Shuzhen Liu, Chenyan Zhao, Jian Ding, Jieqiong Hu, Sandrine I. Samson, Iris A. de Bruijn, for the FSQ01 and FSQ02 Study Groups

Hum Vaccin Immunother. 2022; 18(6): 2132798. Published online 2022 Nov 3. doi: 10.1080/21645515.2022.2132798

PMCID:: PMC9746500

Article PDF–433K

Factors associated with influenza vaccination coverage and willingness in the elderly with chronic diseases in Shenzhen, China

Hongbiao Chen, Qiushuang Li, Minyi Zhang, Zihao Gu, Xiaofeng Zhou, He Cao, Fei Wu, Minyi Liang, Liting Zheng, Juxian Xian, Qing Chen, Qihui Lin

Hum Vaccin Immunother. 2022; 18(6): 2133912. Published online 2022 Oct 21. doi: 10.1080/21645515.2022.2133912

PMCID:: PMC9746395

Article PDF–327K

Licensed Vaccines – Letter

Letter to the editor: Correspondence on Chinese medical personnel vaccinations

Sejal C. Sekhar, Tejas C. Sekhar, Sunitha Thanjavuru

Hum Vaccin Immunother. 2022; 18(6): 2127288. Published online 2022 Nov 18. doi: 10.1080/21645515.2022.2127288

PMCID:: PMC9746435

Article PDF–140K

Licensed Vaccines – Research Article

Comparison of varicella outbreaks in schools in China during different vaccination periods

Xiang Sun, Yanhong Zhu, Hui Sun, Yan Xu, Lei Zhang, Zhiguo Wang

Hum Vaccin Immunother. 2022; 18(6): 2114255. Published online 2022 Aug 22. doi: 10.1080/21645515.2022.2114255

PMCID:: PMC9746505

Article PDF–335K

Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria

Ryoko Sato, Olusesan Ayodeji Makinde, Koeloengan Clement Daam, Bola Lawal

Hum Vaccin Immunother. 2022; 18(6): 2114697. Published online 2022 Aug 30. doi: 10.1080/21645515.2022.2114697

PMCID:: PMC9746486

Article PDF–749K

Effect of difference between EV-A71 virus epidemic strain and “vaccine strain” on neutralizing antibody titer

Yiwei Ding, Zhihai Han

Hum Vaccin Immunother. 2022; 18(6): 2121565. Published online 2022 Sep 16. doi: 10.1080/21645515.2022.2121565

PMCID:: PMC9746541

Article PDF–3.3M

Changes in dendritic complexity and spine morphology following BCG immunization in APP/PS1 mice

Qingqing Li, Xiao Wang, Zhao Hua Wang, Zhenzong Lin, Jieyi Yang, Jichun Chen, Rui Wang, Wenfeng Ye, Ya Li, Yingying Wu, Aiguo Xuan

Hum Vaccin Immunother. 2022; 18(6): 2121568. Published online 2022 Sep 16. doi: 10.1080/21645515.2022.2121568

PMCID:: PMC9746542

Article PDF–3.1M

The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study

Stephanie A. Kujawski, Colleen Burgess, Oren Agi, Zohar Attias-Geva, Matthew Pillsbury, David Greenberg, Goran Bencina, Manjiri Pawaskar

Hum Vaccin Immunother. 2022; 18(6): 2124784. Published online 2022 Oct 31. doi: 10.1080/21645515.2022.2124784

PMCID:: PMC9746549

Article PDF–1.5M

Seroepidemiology of pertussis and diphtheria among healthy adults in Shaanxi Province, northwest China: A large - scale cross-sectional study

Chao Zhang, Weijun Hu, Ruize Wang, Yinan Wang, Yajun Li, Yake Lv, Weixuan Li, Yuan Si, Shaobai Zhang

Hum Vaccin Immunother. 2022; 18(6): 2133913. Published online 2022 Oct 18. doi: 10.1080/21645515.2022.2133913

PMCID:: PMC9746365

Article PDF–1.2M

Measles seroprevalence in persons over one year of age in Chandigarh, India

Joseph L. Mathew, Dakota Riopelle, R K Ratho, Bhavneet Bharti, Mini P. Singh, Vikas Suri, Bradley F. Carlson, Abram L. Wagner, Matthew L. Boulton

Hum Vaccin Immunother. 2022; 18(6): 2136453. Published online 2022 Oct 24. doi: 10.1080/21645515.2022.2136453

PMCID:: PMC9746381

Article PDF–909K

A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency

Lei Zhou, Jingjing Liu, Jia Li, Xuecheng Liu, Jingwu Zhang, Fei Nie, Jianmin Chen, Jing Chai, Jinchao Lv, Minghui Wang, Jiajie Yu, Wenjie Wu, Yuhua Li, Yuhui Zhang

Hum Vaccin Immunother. 2022; 18(6): 2138049. Published online 2022 Nov 21. doi: 10.1080/21645515.2022.2138049

PMCID:: PMC9746391

Article PDF–760K

Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy

Claudio Costantino, Livia Cimino, Nicole Bonaccorso, Arianna Conforto, Martina Sciortino, Francesco Blangiardi, Girolama Bosco, Gaspare Canzoneri, Nicolò Casuccio, Calogero Collura, Mario Cuccia, Roberto Furnari, Pietro Genovese, Giovanni Gucciardi, Maria Angela Randazzo, Gino Enzo Taranto, Mario Palermo, Francesco Vitale

Hum Vaccin Immunother. 2022; 18(6): 2141998. Published online 2022 Nov 3. doi: 10.1080/21645515.2022.2141998

PMCID:: PMC9746355

Article PDF–688K

A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months

Hitt Sharma, Sanjay Lalwani, Sameer Parekh, Pramod Pujari, Sunil Shewale, Sonali Palkar, Neeta Hanumante, Shilpa Gokhale, Jaganathan Ks, Rakesh Kumar, Inderjit Sharma, Sunil Gairola

Hum Vaccin Immunother. 2022; 18(6): 2146435. Published online 2022 Nov 22. doi: 10.1080/21645515.2022.2146435

PMCID:: PMC9746440

Article PDF–283K

Licensed Vaccines – Research Paper

Evaluating the impact of universal varicella vaccination among preschool-aged children in Qingdao, China: An interrupted time-series analysis

Zheng Gao, Feng Yang, Fei Qi, Xiaofan Li, Shanpeng Li

Hum Vaccin Immunother. 2022; 18(6): 2094641. Published online 2022 Jul 12. doi: 10.1080/21645515.2022.2094641

PMCID:: PMC9746422

Article PDF–1.5M

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

Dong Li, Hairong Zhang, Na You, Zhifei Chen, Xiuhui Yang, Hangsu Zhang, Yong Zhou, Ningxuan Zheng, Weiyi Pan

Hum Vaccin Immunother. 2022; 18(6): 2096375. Published online 2022 Aug 11. doi: 10.1080/21645515.2022.2096375

PMCID:: PMC9746472

Article PDF–1.4M

Vaccinations in patients with multiple sclerosis: a real-world, single-center experience

Elvira Sbragia, Dario Olobardi, Giovanni Novi, Caterina Lapucci, Maria Cellerino, Giacomo Boffa, Alice Laroni, Malgorzata Mikulska, Laura Sticchi, Matilde Inglese

Hum Vaccin Immunother. 2022; 18(6): 2099171. Published online 2022 Jul 21. doi: 10.1080/21645515.2022.2099171

PMCID:: PMC9746513

Article PDF–234K

Licensed Vaccines – Review

Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis

Noriko Kitamura, Khawater Bahkali, Elvis D Chem, Billy J Quilty, Tansy Edwards, Michiko Toizumi, Lay-Myint Yoshida

Hum Vaccin Immunother. 2022; 18(6): 2099700. Published online 2022 Jul 21. doi: 10.1080/21645515.2022.2099700

PMCID:: PMC9746369

Article PDF–2.6M

Logistics SF – Commentary

Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries

Saurav Basu, Ruchir Rustagi

Hum Vaccin Immunother. 2022; 18(6): 2059310. Published online 2022 Apr 13. doi: 10.1080/21645515.2022.2059310

PMCID:: PMC9746400

Article PDF–173K

Logistics SF – Review

Information systems for vaccine safety surveillance

Jim P Buttery, Hazel Clothier

Hum Vaccin Immunother. 2022; 18(6): 2100173. Published online 2022 Sep 26. doi: 10.1080/21645515.2022.2100173

PMCID:: PMC9746439

Article PDF–345K

Meningococcal – Meeting Report

Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies

Usa Thisyakorn, Josefina Carlos, Tawee Chotpitayasunondh, Tran M. Dien, Maria Liza A. M. Gonzales, Nguyen T. L. Huong, Zulkifli Ismail, Musa M. Nordin, Anna Lisa T. Ong-Lim, Terapong Tantawichien, Sangita D. Terumalay, Thiem D. Vu, Otavio Cintra, Olakunle Oladehin

Hum Vaccin Immunother. 2022; 18(6): 2110759. Published online 2022 Sep 9. doi: 10.1080/21645515.2022.2110759

PMCID:: PMC9746482

Article PDF–3.0M

Meningococcal – Research Article

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico

Enrique Chacon-Cruz, Erika Zoe Lopatynsky-Reyes, Gloria Huerta-Garcia, Maria Yolanda Cervantes-Apolinar, Adriana Guzman-Holst, Desiree Van Oorschot

Hum Vaccin Immunother. 2022; 18(6): 2103319. Published online 2022 Aug 3. doi: 10.1080/21645515.2022.2103319

PMCID:: PMC9746419

Article PDF–3.8M

Meningococcal – Review

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age

Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson, Philipp Oster

Hum Vaccin Immunother. 2022; 18(6): 2099142. Published online 2022 Aug 10. doi: 10.1080/21645515.2022.2099142

Correction in:: Hum Vaccin Immunother. 2022; 18(6): 2133330.

PMCID:: PMC9746432

Article PDF–1.7M

News, Policy, & Profiles

Human Vaccines & immunotherapeutics: News, June 2022

Hum Vaccin Immunother. 2022; 18(6): 2100139. Published online 2022 Aug 5. doi: 10.1080/21645515.2022.2100139

PMCID:: PMC9746466

Article PDF–176K

Human Vaccines & Immunotherapeutics: News July 2022

Ronald Ellis, Adam Weiss

Hum Vaccin Immunother. 2022; 18(6): 2110829. Published online 2022 Aug 19. doi: 10.1080/21645515.2022.2110829

PMCID:: PMC9746416

Article PDF–164K

Human vaccines & immunotherapeutics: News August 2022

Ronald Ellis, Adam Weiss

Hum Vaccin Immunother. 2022; 18(6): 2123687. Published online 2022 Sep 19. doi: 10.1080/21645515.2022.2123687

PMCID:: PMC9746443

Article PDF–168K

Human vaccines & immunotherapeutics: News September 2022

Ronald Ellis, Adam Weiss

Hum Vaccin Immunother. 2022; 18(6): 2136456. Published online 2022 Oct 21. doi: 10.1080/21645515.2022.2136456

PMCID:: PMC9746454

Article PDF–166K

Human vaccines & immunotherapeutics: News October 2022

Ronald Ellis, Adam Weiss

Hum Vaccin Immunother. 2022; 18(6): 2145073. Published online 2022 Nov 12. doi: 10.1080/21645515.2022.2145073

PMCID:: PMC9746396

Article PDF–124K

Novel Vaccines – Review

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development

Francesco Berlanda Scorza, Laura B. Martin, Audino Podda, Rino Rappuoli

Hum Vaccin Immunother. 2022; 18(6): 2136451. Published online 2022 Nov 3. doi: 10.1080/21645515.2022.2136451

PMCID:: PMC9746511

Article PDF–509K

Pneumococcal – Research Article

Cost-utility analysis of a universal pneumococcal vaccination programme for older adults in Norway

Liv Solvår Nymark, Jacob Dag Berild, Trude Marie Lyngstad, Brita Askeland Winje, Didrik Frimann Vestrheim, Ingeborg Aaberge, Lene Kristine Juvet, Ellen Wolff

Hum Vaccin Immunother. 2022; 18(6): 2101333. Published online 2022 Aug 2. doi: 10.1080/21645515.2022.2101333

Correction in:: Hum Vaccin Immunother. 2023; 19(1): 2177067.

PMCID:: PMC9746426

Article PDF–396K

Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease

Narongkorn Saiphoklang, Jiranan Phadungwatthanachai

Hum Vaccin Immunother. 2022; 18(6): 2102840. Published online 2022 Aug 9. doi: 10.1080/21645515.2022.2102840

PMCID:: PMC9746514

Article PDF–434K

Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt

JP Sevilla, Daria Burnes, Rehab Zakaria El Saie, Hammam Haridy, Matt Wasserman, Sarah Pugh, Johnna Perdrizet, David Bloom

Hum Vaccin Immunother. 2022; 18(6): 2114252. Published online 2022 Sep 7. doi: 10.1080/21645515.2022.2114252

PMCID:: PMC9746463

Article PDF–2.8M

Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial

Lu-Lu Pan, Zhao Gao, Wei-Wei Zhou, Min-Jie Li, Wen-Jian Fang, Wen-Juan Ji, Ying Zhao, Lin Du, Yu-Liang Zhao

Hum Vaccin Immunother. 2022; 18(6): 2116881. Published online 2022 Sep 19. doi: 10.1080/21645515.2022.2116881

PMCID:: PMC9746401

Article PDF–417K

Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease

Charu Sabharwal, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Todd J. Belanger, Bradford D. Gessner, Luis Jodar, Kathrin U. Jansen, William C. Gruber, Daniel A. Scott, Wendy Watson

Hum Vaccin Immunother. 2022; 18(6): 2126253. Published online 2022 Nov 11. doi: 10.1080/21645515.2022.2126253

PMCID:: PMC9746485

Article PDF–2.3M

Pneumonia hospitalizations of children aged <2 years in Poland before (2013–2016) and after (2017–2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine

Amit Bhavsar, Janusz Zaryczański, Anna Wasilewska, Delphine Saragoussi, Raghavendra Devadiga, Chris Colby, Enas Bahar, Jacek Wysocki

Hum Vaccin Immunother. 2022; 18(6): 2128566. Published online 2022 Oct 14. doi: 10.1080/21645515.2022.2128566

PMCID:: PMC9746359

Article PDF–1.5M

Pneumococcal – Review

A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population

Bai Yunhua, Bai Peng, Li Shuping, Zhang Zheng

Hum Vaccin Immunother. 2022; 18(6): 2139123. Published online 2022 Nov 15. doi: 10.1080/21645515.2022.2139123

PMCID:: PMC9746501

Article PDF–1.8M

Public Health – Article Commentary

The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance

Isabel Frost, Anand Balachandran, Sarah Paulin-Deschenaux, Hatim Sati, Mateusz Hasso-Agopsowicz

Hum Vaccin Immunother. 2022; 18(6): 2145069. Published online 2022 Nov 24. doi: 10.1080/21645515.2022.2145069

PMCID:: PMC9746387

Article PDF–2.7M

Public Health – Research Article

Surveillance and risk assessment of health screening for vaccine-preventable diseases among international students in Japan: A cross-sectional study in 2020

Hanako Takahata, Kazunari Onishi, Hidetoshi Nomoto, Noriko Iwamoto, Kuniyoshi Hayashi, Narumi Hori, Satoshi Kutsuna, Eiichi N. Kodama, Norio Ohmagari

Hum Vaccin Immunother. 2022; 18(6): 2136914. Published online 2022 Nov 18. doi: 10.1080/21645515.2022.2136914

PMCID:: PMC9746551

Article PDF–390K

Public Health – Research Paper

Evaluation of the effect of enhanced immunization in adults: A cross-sectional study in the southeast city of China

Wen Ren, Zikang Wu, Ying Liu, Yan Qiu, Jun Yao, Jingjing Ren

Hum Vaccin Immunother. 2022; 18(6): 2096972. Published online 2022 Jul 25. doi: 10.1080/21645515.2022.2096972

PMCID:: PMC9746406

Article PDF–621K

Public Health – Review

Fielding vaccines—challenges and opportunities in outbreaks, complex emergencies, and mass gatherings

Laura J. Fischer, Robert C. Rains, Sherry M. Brett-Major, Mikiko Senga, Debra Holden, David M. Brett-Major

Hum Vaccin Immunother. 2022; 18(6): 2104500. Published online 2022 Aug 5. doi: 10.1080/21645515.2022.2104500

PMCID:: PMC9746477

Article PDF–2.2M

Drivers of and barriers to routine adult vaccination: A systematic literature review

Amanda L. Eiden, Jane Barratt, Mawuli K. Nyaku

Hum Vaccin Immunother. 2022; 18(6): 2127290. Published online 2022 Oct 5. doi: 10.1080/21645515.2022.2127290

PMCID:: PMC9746483

Article PDF–1.0M

A guideline for economic evaluations of vaccines and immunization programs in China

Hai Fang, Chen Chen, Yu Fang, Xiaoning He, Zhiyuan Hou, Minghuan Jiang, Yawen Jiang, Shunping Li, Yang Liu, Binyan Sui, Qiang Sun, Jing Wu, Tingting Xu, Juan Yang, Zundong Yin, Xiaohua Ying, Beibei Yuan, Hui Zheng, Yaming Zheng

Hum Vaccin Immunother. 2022; 18(6): 2132802. Published online 2022 Oct 26. doi: 10.1080/21645515.2022.2132802

PMCID:: PMC9746533

Article PDF–289K

Rotavirus – Research Article

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule

Nicholas Geard, Richard Bradhurst, Nefel Tellioglu, Vicka Oktaria, Jodie McVernon, Amanda Handley, Julie E. Bines

Hum Vaccin Immunother. 2022; 18(6): 2139097. Published online 2022 Nov 21. doi: 10.1080/21645515.2022.2139097

PMCID:: PMC9746532

Article PDF–2.5M

Technology – Brief Report

Challenges and opportunities in current vaccine technology and administration: A comprehensive survey examining oral vaccine potential in the United States

S. Indu Rupassara, John W. Kindt Jr, Nazmul Kazi, Indika Kahanda

Hum Vaccin Immunother. 2022; 18(6): 2114422. Published online 2022 Sep 9. doi: 10.1080/21645515.2022.2114422

PMCID:: PMC9746384

Article PDF–860K

Technology – Research Article

Emerging trends of research on mRNA vaccines: A co-citation analysis

Juan Chen, Ting Zhang, Yan Lu, Xiaoyi Yang, Zhaolian Ouyang

Hum Vaccin Immunother. 2022; 18(6): 2110409. Published online 2022 Aug 26. doi: 10.1080/21645515.2022.2110409

PMCID:: PMC9746488

Article PDF–5.1M

A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database

Hassan H. Musa, Taha H. Musa

Hum Vaccin Immunother. 2022; 18(6): 2135927. Published online 2022 Nov 3. doi: 10.1080/21645515.2022.2135927

PMCID:: PMC9746518

Article PDF–6.8M

Technology – Review

The global mRNA vaccine patent landscape

Mengyao Li, Jianxiong Ren, Xingyong Si, Zhaocai Sun, Pingping Wang, Xiaoming Zhang, Kunmeng Liu, Benzheng Wei

Hum Vaccin Immunother. 2022; 18(6): 2095837. Published online 2022 Jul 7. doi: 10.1080/21645515.2022.2095837

PMCID:: PMC9746484

Article PDF–6.9M

Correction

Hum Vaccin Immunother. 2022; 18(6): 2133330. Published online 2022 Oct 19. doi: 10.1080/21645515.2022.2133330

Corrects:: Hum Vaccin Immunother. 2022; 18(6): 2099142.

PMCID:: PMC9746512

Correction PDF–138K

Articles from Human Vaccines & Immunotherapeutics are provided here courtesy of Taylor & Francis